Cargando…
Anti-Toxoplasma gondii Effects of Lipopeptide Derivatives of Lycosin-I
Toxoplasmosis, caused by Toxoplasma gondii (T. gondii), is a serious zoonotic parasitic disease. We previously found that Lycosin-I exhibited anti-T. gondii activity, but its serum stability was not good enough. In this study, we aimed to improve the stability and activity of Lycosin-I through fatty...
Autores principales: | Liu, Xiaohua, Zhang, Peng, Liu, Yuan, Li, Jing, Yang, Dongqian, Liu, Zhonghua, Jiang, Liping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467082/ https://www.ncbi.nlm.nih.gov/pubmed/37624234 http://dx.doi.org/10.3390/toxins15080477 |
Ejemplares similares
-
Animal venoms: a novel source of anti-Toxoplasma gondii drug candidates
por: Yang, Dongqian, et al.
Publicado: (2023) -
Spider Toxin Peptide Lycosin-I Functionalized Gold Nanoparticles for in vivo Tumor Targeting and Therapy
por: Tan, Huaxin, et al.
Publicado: (2017) -
Anti-Toxoplasma gondii Effects of a Novel Spider Peptide XYP1 In Vitro and In Vivo
por: Liu, Yuan, et al.
Publicado: (2021) -
The Spider Venom Peptide Lycosin-II Has Potent Antimicrobial Activity against Clinically Isolated Bacteria
por: Wang, Yongjun, et al.
Publicado: (2016) -
In vitro anti-Toxoplasma gondii efficacy of synthesised benzyltriazole derivatives
por: Guo, Huanping, et al.
Publicado: (2021)